-
Historical Archive
-
Historical Archive
Usa, electronic prescription systems promote savings
The electronic prescription of medicines can induce doctors to choose the least expensive ones and therefore constitute a favorable factor…
Leggi » -
Historical Archive
Drugs: Assogenerici, finally biosimilar is recognized as a role
(AGI) - Rome, April 3. – "We must evaluate very positively some signs of the change in the image of biosimilar medicines both among…
Leggi » -
Historical Archive
Minister Balduzzi: "Patent only truly innovative drugs"
Minister of Health, Renato Balduzzi, according to the director of Pascale, if there were no national health service, only a…
Leggi » -
Historical Archive
Novartis, that's why India is wrong
The face of an Indian woman in traditional dress and the link to a 'Glivec Information Center' where…
Leggi » -
Historical Archive
A new symbol on «liars»
It is a black inverted triangle, accompanied by an invitation to report any side effects
Leggi » -
Historical Archive
India in the drug war
From now on it will be able to produce the low cost Glivec, an anti-cancer product. Novartis, defeated: "This hinders research" It wants to be ...
Leggi » -
Historical Archive
WORLDNEWS: A judge declares the Pulmicort patent invalid in the United States
A US court has ruled that the patent protecting Pulmicort Respules, AstraZeneca's asthma drug in the United States…
Leggi » -
Historical Archive
Pani (Aifa): "Devolution no longer works for healthcare or pharmaceuticals"
37 revolutionary new molecules are coming. These are biotechnological molecules, monoclonal antibodies, based on biomarkers for hospital wards. I am…
Leggi » -
Historical Archive
Heparins return to the pharmacy. Aifa determines the suspension
"We were right." Thus Alfonso Misasi, national secretary of Federfarma comments on the decision of the Lazio TAR to suspend…
Leggi »